207 related articles for article (PubMed ID: 8164675)
1. The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II.
Caron PR; Watt P; Wang JC
Mol Cell Biol; 1994 May; 14(5):3197-207. PubMed ID: 8164675
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and expression of the Candida albicans TOP2 gene allows study of fungal DNA topoisomerase II inhibitors in yeast.
Keller BA; Patel S; Fisher LM
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):329-39. PubMed ID: 9164874
[TBL] [Abstract][Full Text] [Related]
3. Analysis of functional domain organization in DNA topoisomerase II from humans and Saccharomyces cerevisiae.
Jensen S; Andersen AH; Kjeldsen E; Biersack H; Olsen EH; Andersen TB; Westergaard O; Jakobsen BK
Mol Cell Biol; 1996 Jul; 16(7):3866-77. PubMed ID: 8668204
[TBL] [Abstract][Full Text] [Related]
4. Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate Leishmania donovani.
Sengupta T; Mukherjee M; Mandal C; Das A; Majumder HK
Nucleic Acids Res; 2003 Sep; 31(18):5305-16. PubMed ID: 12954766
[TBL] [Abstract][Full Text] [Related]
5. Catalysis of ATP hydrolysis by two NH(2)-terminal fragments of yeast DNA topoisomerase II.
Olland S; Wang JC
J Biol Chem; 1999 Jul; 274(31):21688-94. PubMed ID: 10419479
[TBL] [Abstract][Full Text] [Related]
6. Intradimerically tethered DNA topoisomerase II is catalytically active in DNA transport.
Lindsley JE
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2975-80. PubMed ID: 8610153
[TBL] [Abstract][Full Text] [Related]
7. Function of the hydrophilic carboxyl terminus of type II DNA topoisomerase from Drosophila melanogaster. II. In vivo studies.
Crenshaw DG; Hsieh T
J Biol Chem; 1993 Oct; 268(28):21335-43. PubMed ID: 8407972
[TBL] [Abstract][Full Text] [Related]
8. The hydrophilic, protease-sensitive terminal domains of eucaryotic DNA topoisomerases have essential intracellular functions.
Shaiu WL; Hu T; Hsieh TS
Pac Symp Biocomput; 1999; ():578-89. PubMed ID: 10380229
[TBL] [Abstract][Full Text] [Related]
9. Ectopic expression of inactive forms of yeast DNA topoisomerase II confers resistance to the anti-tumour drug, etoposide.
Vassetzky YS; Alghisi GC; Roberts E; Gasser SM
Br J Cancer; 1996 May; 73(10):1201-9. PubMed ID: 8630279
[TBL] [Abstract][Full Text] [Related]
10. The regulation of DNA topoisomerase II by casein kinase II.
Alghisi GC; Roberts E; Cardenas ME; Gasser SM
Cell Mol Biol Res; 1994; 40(5-6):563-71. PubMed ID: 7735331
[TBL] [Abstract][Full Text] [Related]
11. Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain.
Adachi N; Miyaike M; Kato S; Kanamaru R; Koyama H; Kikuchi A
Nucleic Acids Res; 1997 Aug; 25(15):3135-42. PubMed ID: 9224616
[TBL] [Abstract][Full Text] [Related]
12. Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine.
Wasserman RA; Wang JC
Cancer Res; 1994 Apr; 54(7):1795-800. PubMed ID: 8137294
[TBL] [Abstract][Full Text] [Related]
13. Intracellular localization of the Apn1 DNA repair enzyme of Saccharomyces cerevisiae. Nuclear transport signals and biological role.
Ramotar D; Kim C; Lillis R; Demple B
J Biol Chem; 1993 Sep; 268(27):20533-9. PubMed ID: 7690756
[TBL] [Abstract][Full Text] [Related]
14. Identification of the yeast TOP3 gene product as a single strand-specific DNA topoisomerase.
Kim RA; Wang JC
J Biol Chem; 1992 Aug; 267(24):17178-85. PubMed ID: 1324925
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of a nuclear topoisomerase II from Nicotiana tabacum that functionally complements a temperature-sensitive topoisomerase II yeast mutant.
Singh BN; Mudgil Y; Sopory SK; Reddy MK
Plant Mol Biol; 2003 Jul; 52(5):1063-76. PubMed ID: 14558665
[TBL] [Abstract][Full Text] [Related]
16. Cloning, functional analysis and post-transcriptional regulation of a type II DNA topoisomerase from Leishmania infantum. A new potential target for anti-parasite drugs.
Hanke T; Ramiro MJ; Trigueros S; Roca J; Larraga V
Nucleic Acids Res; 2003 Aug; 31(16):4917-28. PubMed ID: 12907735
[TBL] [Abstract][Full Text] [Related]
17. A distinct subnuclear localization of mammalian DNA topoisomerase IIbeta in yeast.
Sakaguchi A; Akashi T; Kikuchi A
Biochem Biophys Res Commun; 2001 May; 283(4):876-82. PubMed ID: 11350066
[TBL] [Abstract][Full Text] [Related]
18. A mutation in yeast TOP2 homologous to a quinolone-resistant mutation in bacteria. Mutation of the amino acid homologous to Ser83 of Escherichia coli gyrA alters sensitivity to eukaryotic topoisomerase inhibitors.
Hsiung Y; Elsea SH; Osheroff N; Nitiss JL
J Biol Chem; 1995 Sep; 270(35):20359-64. PubMed ID: 7657608
[TBL] [Abstract][Full Text] [Related]
19. Failure to relax negative supercoiling of DNA is a primary cause of mitotic hyper-recombination in topoisomerase-deficient yeast cells.
Trigueros S; Roca J
J Biol Chem; 2002 Oct; 277(40):37207-11. PubMed ID: 12151411
[TBL] [Abstract][Full Text] [Related]
20. Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.
Patel S; Jazrawi E; Creighton AM; Austin CA; Fisher LM
Mol Pharmacol; 2000 Sep; 58(3):560-8. PubMed ID: 10953049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
